BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Light Sciences Oncology, Inc. 

34931 SE Douglas Street, Suite 200

Snoqualmie  Washington  98065  U.S.A.
Phone: 425-369-2800 Fax: 425-369-2801


SEARCH JOBS


Industry
Biotechnology

Segment
Start Up





 Company News
Light Sciences Oncology, Inc. Stumbles in Clinical Trial, Layoffs Loom 10/5/2011 9:47:14 AM    More...
Light Sciences Oncology, Inc. Elects Dennis Langer, M.D., J.D. to Its Board of Directors 5/11/2011 8:53:33 AM    More...
Light Sciences Oncology, Inc. CEO Exits for New Job; Company Still Waiting for Pivotal Results 11/24/2010 7:58:58 AM    More...
Light Sciences Oncology, Inc. Wins Therapeutic Discovery Grants Totaling $488,958 from the U.S. Government for Development of Aptocine in Liver Cancer and BPH 11/3/2010 10:36:59 AM    More...
Light Sciences Oncology, Inc. Elects Mitchell Hymowitz, Founder of CFO Services LLC, to Its Board of Directors 10/18/2010 12:26:02 PM    More...
Light Sciences Oncology, Inc. Elects Akbar Seddigh, Chairman of Elekta AB to Its Board of Directors 11/23/2009 9:55:53 AM    More...
Light Sciences Oncology, Inc. Raises $35 Million Bridge 11/6/2009 8:01:23 AM    More...
Light Sciences Oncology, Inc. Expands Development of Novel Targeted Drug Aptocine(TM) For Prostate Conditions With Start-Up of Phase 2 BPH Trial 8/18/2009 7:24:33 AM    More...
Light Sciences Oncology, Inc.: First Pediatric Patient Treated With Aptocine(TM), a Novel Light-Activated Drug, in Neurofibromatosis 8/12/2009 8:16:44 AM    More...
Light Sciences Oncology, Inc. Announces Results of Study on Immunotherapeutic Mechanism of Aptocine(TM), a Novel Light-Activated Drug Therapy for Cancer 5/18/2009 9:07:25 AM    More...
1234

//-->